TTR mouse Monoclonal Antibody(2B12)

This gene encodes transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid. Transthyretin is a carrier protein; it transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The protein consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, carpal tunnel syndrome, etc.

Introducing the TTR Mouse Monoclonal Antibody (2B12), a cutting-edge product designed to revolutionize the field of biomedical research. This highly specialized antibody is meticulously crafted to target and detect Transthyretin (TTR), a protein of utmost significance in various physiological processes.

The TTR Mouse Monoclonal Antibody (2B12) boasts exceptional specificity and sensitivity, enabling researchers to accurately identify and quantify TTR in biological samples. Its unrivaled performance is attributed to the advanced hybridoma technology employed during its development, ensuring the production of a highly pure and reliable antibody.

With its remarkable affinity for TTR, this antibody facilitates a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting. Researchers can confidently rely on the TTR Mouse Monoclonal Antibody (2B12) to deliver precise and reproducible results, thereby advancing their investigations in the realms of neurodegenerative diseases, cardiovascular disorders, and metabolic syndromes.

Furthermore, this antibody exhibits exceptional stability and longevity, ensuring consistent performance over an extended period. Its formulation is optimized to minimize non-specific binding, thereby reducing background noise and enhancing signal-to-noise ratios. This attribute, coupled with its ease of use, makes the TTR Mouse Monoclonal Antibody (2B12) an indispensable tool for both seasoned scientists and aspiring researchers.

In summary, the TTR Mouse Monoclonal Antibody (2B12) represents a breakthrough in the field of biomedical research, offering unparalleled specificity, sensitivity, and reliability. Its versatility and robustness make it an invaluable asset for elucidating the intricate mechanisms underlying various diseases. Embrace the future of scientific exploration with the TTR Mouse Monoclonal Antibody (2B12) and unlock new frontiers in biomedical research.